mRNA-1975
Phase 2Completed 1 views this week 0 watching
0
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Lyme Disease
Conditions
Lyme Disease
Trial Timeline
Jul 26, 2023 → May 30, 2025
NCT ID
NCT05975099About mRNA-1975
mRNA-1975 is a phase 2 stage product being developed by Moderna for Lyme Disease. The current trial status is completed. This product is registered under clinical trial identifier NCT05975099. Target conditions include Lyme Disease.
What happened to similar drugs?
0 of 3 similar drugs in Lyme Disease were approved
Approved (0) Terminated (0) Active (3)
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT05975099 | Phase 2 | Completed |
Competing Products
8 competing products in Lyme Disease
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| VLA15 with Alum + VLA15 without Alum | Pfizer | Phase 1 | 29 |
| VLA15 + Placebo | Pfizer | Phase 2 | 35 |
| VLA15 + Placebo | Pfizer | Phase 3 | 47 |
| VLA15 + Placebo | Pfizer | Phase 2 | 35 |
| VLA15 | Pfizer | Phase 3 | 44 |
| VLA15 | Pfizer | Phase 3 | 40 |
| VLA15 + Placebo | Pfizer | Phase 2 | 35 |
| Multivalent recombinant OspA Lyme Borreliosis Vaccine + Multivalent recombinant OspA Lyme Borreliosis Vaccine + Multivalent recombinant OspA Lyme Borreliosis Vaccine | Baxter | Phase 1/2 | 29 |